Previous 10 | Next 10 |
2024-01-10 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Members of NeoGenomics’ management team will deliver a presentat...
2023-12-28 14:52:16 ET More on NeoGenomics NeoGenomics, Inc. 2023 Q3 - Results - Earnings Call Presentation NeoGenomics, Inc (NEO) Q3 2023 Earnings Call Transcript NeoGenomics: Short-Term Upsides Possible, Long-Term Not Supported By Economic Value Natera wins...
2023-12-28 13:01:35 ET Gainers: Sidus Space ( SIDU ) +193% . Cingulate ( CING ) +167% . Nova Lifestyle ( NVFY ) +146% . Jin Medical International ( ZJYL ) +58% . Ucommune International ( UK ) +53% . Microbot Medical ( MBOT ...
FORT MYERS, FL / ACCESSWIRE / December 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services company, today announced that NeoGenomics Laboratories, Inc., a subsidiary of NeoGenomics Inc., will appeal the preliminary injunction issued by the United States...
2023-12-28 06:48:40 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Merck to use Natera's database for oncology drug res...
2023-12-19 16:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR ® assay for minimal residual disease (MRD) will be presented at the 46 th annual San Antonio Breast Cancer Symposi...
FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler 35 th Annual Global Healthcare Conference in New York City. Members of NeoGenomics' managemen...
2023-11-06 20:03:03 ET NeoGenomics, Inc (NEO) Q3 2023 Earnings Conference Call November 6, 2023 04:30 AM ET Company Participants Kendra Sweeney - VP, IR Chris Smith - CEO Jeff Sherman - CFO Vishal Sikri - President, Advanced Diagnostics Warren Stone - Pre...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics Inc. Company Name:
NEO Stock Symbol:
NASDAQ Market:
First Quarter Revenue Increased 14% to $156 Million NeoGenomics, Inc. (NASDAQ: NEO) (the “ Company ” ) , a leading provider of oncology testing and global contract research services, today announced its first-quarter results for the period ended March 31, 2024....
LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...
In the latest cryptocurrency market update, Neo (NEO) has significantly outperformed Dogwifhat (WIF) with a price surge of over 35%. What Happened:...